我要投票 香雪XPH在医疗器械行业中的票数:713
· 外 推 电 报 ·
2026-01-07 11:31:48 星期三

【香雪XPH是哪个国家的品牌?】

香雪XPH是什么牌子?「香雪XPH」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人王董在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪XPH品牌出海!将品牌入驻外推网,定制香雪XPH品牌推广信息,可以显著提高香雪XPH产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

广州市香雪制药股份有限公司,始于1986年,广东省名牌,药典标准制定者,大中药健康产业领先者,现代化高新技术医药企业


“十里梅花浑似雪,萝岗香雪映朝阳。”诗人郭沫若赋诗赞赏的羊城八景之一“萝岗香雪”, 正是香雪制药的发祥地。1986年萝岗制药厂成立,1997年改制为广州市香雪制药股份有限公司,于2010年在中国深圳证券交易所公开发行股票(IPO)挂牌上市(股票代码:300147)。秉承“厚生、臻善、维新”的经营理念,公司把发展中药和实现中药现代化作为长远发展战略,经多年发展,现已成为拥有自主知识产权、自主品牌、自主创新能力的中药现代化的领军企业和技术企业,形成中药资源开发、中药先进制造、现代物流配送、新药创制的完整产业链。香雪制药先后在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司并投资兴建大规模的GMP生产基地和GAP药材种植基地,形成了新型中药饮片、中成药、功能健康食品(饮料)、养生保健等产品群所组成的大中药健康产业,在中国创造就业职位一万余个。

数字化中药

香雪制药致力于中药现代化的研究和实践,在中药现代化的关键技术——中成药质量控制技术、现代制剂技术、中药给药途径创新等研究取得丰硕成果及突破。香雪制药建立了以“现代中药指纹图谱质量控制技术”为核心的现代中药集成创新系统,应用指纹图谱质控技术,通过计算机相似度分析系统使得成分复杂的中药质量得到有效控制;应用中药临床循证医学评价方法,通过大样品、多中心的大规模临床数据评价使中药疗效准确与经济。香雪制药引进全球先进的信息管理系统,使中药生产经营、销售服务过程实现全面信息资源管理,对企业资源、供应链、客户关系、节能环保、智能办公等方面完成高度集成,使中药企业管理与大数据时代接轨。


英文翻译:Guangzhou Xiangxue Pharmaceutical Co., Ltd. started in 1986. It is a famous brand in Guangdong Province, a standard maker of Pharmacopoeia, a leader in the health industry of traditional Chinese medicine, and a modern high-tech pharmaceutical enterprise Luogang Xiangxue, one of the eight sceneries in Yangcheng, is the birthplace of Xiangxue pharmaceutical. Luogang pharmaceutical factory was established in 1986, and was restructured into Guangzhou Xiangxue Pharmaceutical Co., Ltd. in 1997. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300147). Adhering to the business philosophy of "health, perfection and renovation", the company takes the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as its long-term development strategy. After years of development, the company has become a leading enterprise and technical enterprise with independent intellectual property rights, independent brand and independent innovation ability, forming the development of traditional Chinese medicine resources, advanced manufacturing of traditional Chinese medicine, modern logistics and distribution, and the creation of new drugs A complete industrial chain. Xiangxue pharmaceutical has successively set up 18 companies in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia and invested in the construction of large-scale GMP production base and gap medicine planting base, forming a large traditional Chinese medicine health industry composed of new traditional Chinese medicine pieces, proprietary Chinese medicine, functional health food (beverage), health care and other product groups, creating jobs in China More than 10000. Xiangxue pharmaceutical is committed to the research and practice of the modernization of traditional Chinese medicine, and has made fruitful achievements and breakthroughs in the key technologies of the modernization of traditional Chinese medicine, such as the quality control technology of traditional Chinese medicine, the modern preparation technology, and the innovation of the way of administration of traditional Chinese Medicine. Xiangxue pharmaceutical has established a modern integrated innovation system of traditional Chinese medicine with "modern fingerprint quality control technology" as the core. By using fingerprint quality control technology and computer similarity analysis system, the quality of traditional Chinese medicine with complex components can be effectively controlled. By using the clinical evidence-based medicine evaluation method of traditional Chinese medicine, the quality of traditional Chinese medicine can be effectively controlled through large-scale clinical data evaluation of large samples and multi centers The therapeutic effect is accurate and economical. Xiangxue pharmaceutical introduced the world's advanced information management system to realize the comprehensive information resource management in the process of Chinese medicine production, operation and sales service, and highly integrated the enterprise resources, supply chain, customer relationship, energy conservation and environmental protection, intelligent office, etc., so as to make the Chinese medicine enterprise management in line with the big data era.

本文链接: https://www.waitui.com/brand/5a03ebbad.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

2025年12月份全球制造业采购经理指数较上月微幅下降

今天(7日),中国物流与采购联合会发布2025年12月份全球制造业采购经理指数,指数较上月微幅下降,全球经济基本平稳。2025年12月份全球制造业采购经理指数为49.5%,较上月微幅下降0.1个百分点,连续10个月运行在49%~50%的区间内。综合指数变化,12月全球制造业维持弱势复苏格局,但复苏强度尚未形成有效支撑,仍需进一步巩固提升。(央视新闻)

2小时前

又有茅台经销商跟进,促销1499元/瓶飞天茅台

“1月10日,抢1499元飞天茅台。”苏州鲁智深网络科技有限公司负责人近日在其官方视频号中表示。“此次直播,就是想跟随茅台酒厂的脚步,推动真正的全面市场化,直接面对消费者。”该负责人称,当前市场上有关“茅台价格已跌破1499元/瓶”的说法并不准确。“业内普遍知道,目前飞天茅台的批发调货价仍在1500元/瓶以上。”(上证报)

2小时前

环球音乐与英伟达宣布开展AI音乐创作与研究合作

当地时间1月6日,据报道,环球音乐集团与英伟达公司达成合作,将共同开展人工智能音乐创作与研究合作。环球音乐表示,双方将专注于利用AI技术优化乐迷的音乐发现方式和艺人互动体验。(界面)

2小时前

算力巨头超聚变启动上市辅导

据证监会官网显示,超聚变数字技术股份有限公司于2026年1月6日正式启动上市辅导,中信证券担任辅导机构。公开资料显示,超聚变的前身是华为的X86服务器业务部门。2021年,华为将X86服务器业务剥离,成立超聚变,并落户河南郑州。(上证报)

2小时前

谷歌重金押注中国AR企业,与XREAL深化战略合作

36氪获悉,CES 2026期间,谷歌与XREAL联合宣布达成深度长期战略合作。来自中国的AR创新企业XREAL是谷歌在AR眼镜领域的唯一硬件合作伙伴,已连续四年独占全球AR眼镜市场份额第一,双方首款合作产品Project Aura将于今年上市。另据知情人士透露,谷歌或将于年内完成对XREAL的投资,以此完善Android XR端到端生态圈,应对Meta、苹果的竞争挑战。

2小时前

本页详细列出关于香雪XPH的品牌信息,含品牌所属公司介绍,香雪XPH所处行业的品牌地位及优势。
咨询